Search results
Results from the WOW.Com Content Network
Chronic solvent-induced encephalopathy (CSE) is a condition induced by long-term exposure to organic solvents, often—but not always—in the workplace, that lead to a wide variety of persisting sensorimotor polyneuropathies and neurobehavioral deficits even after solvent exposure has been removed.
Although it has been defined as an extension of pneumoconiosis, there is no scientific evidence for a similar disease related to volcanic silica particle exposures. [8] Subsequently, the word was used in Frank Scully's puzzle book Bedside Manna, after which time, members of the N.P.L. campaigned to include the word in major dictionaries. [9] [10]
A rare disease is technically defined (in the European Union) as a disease that is found in fewer than 5 people per every 10,000 people. ...
An air quality monitor. Human exposure to aerosols has a variety of adverse health effects. [7] Building occupants complain of symptoms such as sensory irritation of the eyes, nose, or throat; neurotoxic or general health problems; skin irritation; nonspecific hypersensitivity reactions; infectious diseases; [8] and odor and taste sensations. [9]
From that month through January 2016, HPD issued more than 10,000 violations for dangerous lead paint conditions in units with children under 6, the age group most at risk of ingesting toxic paint. Half of the violations were in just 10 percent of the city’s zip codes, low-income neighborhoods in the Bronx, Brooklyn and northern Manhattan, a ...
Schnitzler syndrome or Schnitzler's syndrome is a rare disease characterised by onset around middle age of chronic hives (urticaria) and periodic fever, bone and joint pain (sometimes with joint inflammation), weight loss, malaise, fatigue, swollen lymph glands and enlarged spleen and liver.
A rare disease is any disease that affects a small percentage of the population. In some parts of the world, the term orphan disease describes a rare disease whose rarity results in little or no funding or research for treatments, without financial incentives from governments or other agencies. Orphan drugs are medications targeting orphan ...
There are more than 6,000 known rare diseases, and it is estimated that about 25 million Americans are affected by them (as of 2002). [2] Prior to the RDA was the Orphan Drug Act of 1983, which was designed to facilitate the development and commercialization of drugs to treat rare diseases, termed orphan drugs. This act, however, did not ...